ProKidney Expands Executive Team to Advance Phase 3 Clinical Program
===============
#487e5f34 ver:0.07
KLA Corporation, a leading provider of process control solutions for the semiconductor industry, announced its Q1 2024 earnings results during a conference call and webcast. The company reported strong financial performance for the September quarter, with $2.4 billion in revenue and a non-GAAP diluted EPS of $5.74. CEO Rick Wallace highlighted the strength and relevance of KLA's process control portfolio and emphasized the continued growth of its service business. CFO Bren Higgins provided financial highlights and guidance for the December quarter, projecting total revenue of $2.45 billion and a non-GAAP gross margin of 61.5%. KLA also shared its outlook for the wafer fab equipment market, expecting a decline of approximately 16% in 2023. The company remains committed to driving differenti...
#newstr #KlaCorporation #Klarna #Skf #KornitDigital #Kroger #Prokidney #FinancialPerformance #StrategicShifts #ExecutiveTeam #Phase3ClinicalProgram